Clinical Trial Detail

NCT ID NCT02179918
Title A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

Advanced Solid Tumor

Therapies

Utomilumab

Pembrolizumab

Age Groups: adult

No variant requirements are available.